Lutikizumab (ABT-981)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutikizumab (ABT-981), covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy [Phase 2]